JW THERAP-B News

JW THERAP-B: GRANT OF EXTENSION OF WAIVER FROM STRICT COMPLIANCE WITH RULES 14A.52 AND 14A.53 OF THE LISTING RULES UNDER THE LICENSE AND STRATEGIC ALLIANCE AGREEMENT

Apr 25 19:06 ET

JW THERAP-B: Form of proxy for the Annual General Meeting to be held on June 18, 2024

Apr 25 18:58 ET

JW THERAP-B: NOTICE OF ANNUAL GENERAL MEETING

Apr 25 18:53 ET

JW THERAP-B: PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES, TRANSFER SHARES OUT OF TREASURY AND REPURCHASE SHARES AND RE-ELECTION OF DIRECTORS AND RE-APPOINTMENT OF AUDITOR AND ADOPTION OF NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING

Apr 25 18:48 ET

JW THERAP-B: PROPOSED ADOPTION OF NEW ARTICLES OF ASSOCIATION

Apr 25 18:41 ET

JW THERAP-B: 2023 Environmental, Social and Governance Report

Apr 25 18:35 ET

JW THERAP-B: 2023 ANNUAL REPORT

Apr 25 18:21 ET

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 5 04:32 ET

JW THERAP-B: Next Day Disclosure Return

Apr 2 07:36 ET

JW THERAP-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 AND CHANGE IN USE OF NET PROCEEDS FROM LISTING

Mar 20 04:34 ET

JW THERAP-B: NOTICE OF BOARD MEETING

Mar 8 03:45 ET

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 6 03:56 ET

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 5 03:39 ET

JW THERAP-B: Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Jan 19 03:35 ET

JW THERAP-B: Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Jan 19 03:33 ET

JW THERAP-B: VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE - NMPA ACCEPTANCE OF THE SUPPLEMENTAL BIOLOGICAL LICENSE APPLICATION FOR CARTEYVA IN PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA

Jan 4 08:29 ET

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 4 03:39 ET

JW THERAP-B: VOLUNTARY ANNOUNCEMENT - STRATEGIC PARTNERSHIP WITH 2SEVENTY BIO, INC.

Jan 2 07:01 ET

JW THERAP-B: RESIGNATION OF CHIEF FINANCIAL OFFICER

Dec 15, 2023 07:00 ET

JW THERAP-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 5, 2023 03:43 ET